great read for those interested - validates the design and implementation of the insomnia / anxiety phase III trial pathway being pursued by the company
https://www.bloomberg.com/press-releases/2023-11-08/peer-reviewed-scientific-study-independently-confirms-pressure-biosciences-ultrashear-nanoemulsion-platform-vastly
Avecho
Epidiolex + TPM3 demonstrated a 400% increase in bioavailability over Epidiolex alone in dogs
great read for those interested - validates the design and...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $540 | 270K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 13918600 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 41116983 | 27 |
View Market Depth
| Last trade - 10.35am 05/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |